Blood News and Research

RSS

Patent issued for GHB, date rape drug test

A patent for a highly sensitive test to detect the presence of the "date rape" drug, GHB, has recently been granted to the University of California, Santa Barbara.

9 Jun 2004

New statistical techniques for cancer diagnosis

CSIRO statisticians have developed a new way to subtype paediatric Acute Lymphoblastic Leukaemia (ALL), the most common form of cancer in children under 12.

9 Jun 2004

Foundation for poor heart health laid early in life

Heart disease - long viewed as a scourge of adulthood - is a growing threat to children because of soaring rates of obesity and related problems, such as diabetes.

9 Jun 2004

SU11248 proves effective in the treatment of gastrointestinal stromal tumors

A drug originally developed to block the formation of blood vessels in tumors has been shown to overcome resistance to treatment with Gleevec in patients with gastrointestinal stromal tumors (GIST).

9 Jun 2004

Lovastatin and Simvastatin have a significantly reduced risk of prostate cancer

Men who take even small amounts of common cholesterol-lowering drugs such as Lovastatin and Simvastatin have a significantly reduced risk of prostate cancer, according to a new study by Oregon Health & Science University Cancer Institute researchers.

9 Jun 2004

Discovery may help those susceptible to deep-vein thrombosis, strokes and recurrent miscarriages

Australian researchers at University of New South Wales have identified a mechanism than can cause blood clots - a discovery with implications for those susceptible to deep-vein thrombosis, strokes and recurrent miscarriages.

7 Jun 2004

GenoMed launches campaign to improve patient outcomes for diabetes, high blood pressure and emphysema

GenoMed, Inc., a Next Generation DM™ (Disease Management) company that uses its expertise in genomics to improve clinical outcomes, announced today the launch of its national marketing campaign to improve patient outcomes for diabetes, high blood pressure and emphysema.

7 Jun 2004

Gene mutation found in some women may decrease effectiveness of tamoxifen breast cancer drug

Researchers from the Johns Hopkins Kimmel Cancer Center, Indiana University and the University of Michigan have found that some women have a gene mutation that may decrease the effectiveness of tamoxifen, a commonly used breast cancer drug.

7 Jun 2004

Chemotherapy regimen more effective and more toxic in Japanese patients than in American patients

A chemotherapy regimen commonly used to treat non-small cell lung cancer is both more effective and more toxic in Japanese patients than in American patients, researchers reported Saturday at the annual meeting of the American Society of Clinical Oncologists.

7 Jun 2004

Antioxidants in fruits and vegetables, might reduce the risk of ischemic stroke

Sufficient blood levels of carotenoids, a family of antioxidants in fruits and vegetables, might reduce the risk of ischemic stroke, according to a study published today in the rapid access issue of Stroke: Journal of the American Heart Association.

7 Jun 2004

New study to determine the effectiveness of a new pediatric screening method for Wilson's disease

Mayo Clinic seeks normal healthy children and young adults between the ages of 3 months and 18 years for a research study to determine the effectiveness of a new pediatric screening method for Wilson's disease.

7 Jun 2004

Investigational drug, LAF237 improved glycemic control in patients with type 2 diabetes

Research presented today showed that the investigational drug, LAF237, the first in a new class, improved glycemic control in patients with type 2 diabetes. In this study, LAF237, which is administered as a tablet to be taken orally, was added to the standard diabetes treatment metformin in patients whose diabetes was not adequately controlled by metformin alone.

7 Jun 2004

Combination treatment may help type 2 diabetes patients

New research presented by Peter Weissman, M.D., from the University of Miami, at the 64th Annual Scientific Sessions of the American Diabetes Association shows that combination treatment with rosiglitazone maleate and metformin significantly improves certain markers of cardiovascular disease risk in patients with type 2 diabetes compared to metformin alone.

6 Jun 2004

Multi-targeted anticancer drug shows promise as treatment for metastatic renal cell cancer

A new multi-targeted anticancer drug called SU11248 has shown very promising results in the treatment for metastatic renal cell cancer, one of the most chemotherapy resistant of all cancers.

6 Jun 2004

Velcade major improvement over standard therapy for relapsed multiple myeloma

Early results from a major, international Phase III clinical trial decisively show that recurrent multiple myeloma is more effectively treated with the drug bortezomib (trade name: Velcade TM) than with dexamethasone, a drug that for decades has been the standard therapy for relapsed disease, researchers at Dana-Farber Cancer Institute report.

6 Jun 2004

Overweight families unaware & unconcerned about risk of diabetes and premature heart disease

Two new studies show that many children are at high risk for diabetes and premature heart disease, according to British and U.S. reports here today at the American Diabetes Association's 64th Annual Scientific Sessions.

5 Jun 2004

Research seeks best mix of hope and care for leukaemia sufferers

Funding has been granted for research seeking the best care options for patients with leukaemia and other blood disorders and their families.

5 Jun 2004

New method for identifying proteins found in trace quantities in the blood

Using conventional technologies, researchers supported by the National Cancer Institute (Science Applications International Corporation-Frederick, Inc. (SAIC)) have developed a new method for identifying proteins found in trace quantities in the blood.

5 Jun 2004

Depression, insulin regimen linked to poor diabetes control

In the largest study of diabetes and depression conducted to date, researchers at Duke University Medical Center have found a clear link between the complexity of the self-care regimens in patients with diabetes and the effect of depression on diabetes control.

5 Jun 2004

Exenatide shows significant improvements in glucose control for people With type 2 diabetes

Amylin Pharmaceuticals, Inc., and Eli Lilly and Company have presented detailed 30-week data from two of the three pivotal Phase 3 studies of exenatide during a late-breaking session at the American Diabetes Association's (ADA) 64th Scientific Sessions in Orlando, Florida.

5 Jun 2004

Blood News and Research

Patent issued for GHB, date rape drug test

New statistical techniques for cancer diagnosis

Foundation for poor heart health laid early in life

SU11248 proves effective in the treatment of gastrointestinal stromal tumors

Lovastatin and Simvastatin have a significantly reduced risk of prostate cancer

Discovery may help those susceptible to deep-vein thrombosis, strokes and recurrent miscarriages

GenoMed launches campaign to improve patient outcomes for diabetes, high blood pressure and emphysema

Gene mutation found in some women may decrease effectiveness of tamoxifen breast cancer drug

Chemotherapy regimen more effective and more toxic in Japanese patients than in American patients

Antioxidants in fruits and vegetables, might reduce the risk of ischemic stroke

New study to determine the effectiveness of a new pediatric screening method for Wilson's disease

Investigational drug, LAF237 improved glycemic control in patients with type 2 diabetes

Combination treatment may help type 2 diabetes patients

Multi-targeted anticancer drug shows promise as treatment for metastatic renal cell cancer

Velcade major improvement over standard therapy for relapsed multiple myeloma

Overweight families unaware & unconcerned about risk of diabetes and premature heart disease

Research seeks best mix of hope and care for leukaemia sufferers

New method for identifying proteins found in trace quantities in the blood

Depression, insulin regimen linked to poor diabetes control

Exenatide shows significant improvements in glucose control for people With type 2 diabetes

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News